Literature DB >> 11353646

Salmonella excretion after cessation of tosufloxacin therapy in acute nontyphoid salmonella enterocolitis.

K Ohnishi1, K Kimura.   

Abstract

Symptomatic nontyphoid salmonella enterocolitis patients were treated with tosufloxacin (TFLX) at oral doses of 150 mg three times a day for 5 to 7 days, but bacterial relapse without symptoms occurred in 85% of the patients within 15 days after the cessation of therapy. Our study indicates that TFLX may not be an ideal drug against symptomatic salmonella enterocolitis from a bacteriological point of view.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11353646      PMCID： PMC90566          DOI： 10.1128/AAC.45.6.1892-1893.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae.

Authors:  B Aserkoff; J V Bennett
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

2.  Oral administration of fluoroquinolones in the treatment of typhoid fever and paratyphoid fever in Japan.

Authors:  K Ohnishi; K Kimura; G Masuda; T Tsunoda; M Obana; H Yoshida; T Goto; Y Sakaue; Y K Kim; M Sakamoto; H Sagara
Journal:  Intern Med       Date:  2000-12       Impact factor: 1.271

3.  Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.

Authors:  T Noumi; N Nishida; S Minami; Y Watanabe; T Yasuda
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo.

Authors:  J D Nelson; H Kusmiesz; L H Jackson; E Woodman
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

5.  Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

Authors:  H E Pichler; G Diridl; K Stickler; D Wolf
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers.

Authors:  M A Neill; S M Opal; J Heelan; R Giusti; J E Cassidy; R White; K H Mayer
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

7.  [Clinical trial of T-3262 on acute enteritis. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].

Authors:  T Aoki; Y Matsubara; H Sagara; I Tomizawa; Y Takizawa; Y Nitta; T Seo; M Kamimura; G Masuda; M Negishi
Journal:  Kansenshogaku Zasshi       Date:  1989-06

8.  [Clinical trial of T-3262 (Tosufloxacin tosilate) on Salmonella enteritis, and fecal drug concentration and change in the fecal microflora in the acute diarrheal patients. Japan Research Committee of T-3262, Research Group for Acute Infectious Enteritis].

Authors:  T Aoki; Y Matsubara; H Sagara; N Shimizu; I Tomizawa; Y Takizawa; Y Nitia; T Seo; M Kamimura; N Kanehisa
Journal:  Kansenshogaku Zasshi       Date:  1989-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.